About the Product

Description


Caspofungin 50 mg Injection is a potent antifungal medication used for the treatment of serious fungal infections such as candidemia and invasive aspergillosis. It is commonly administered in hospitalized patients, especially those with compromised immune systems.

Caspofungin works by inhibiting the synthesis of beta-(1,3)-D-glucan, an essential component of the fungal cell wall. This leads to weakening of the fungal structure and effective elimination of infection.

Common side effects may include fever, headache, nausea, vomiting, diarrhea, and infusion-related reactions such as rash or flushing. Some patients may experience elevated liver enzymes. Rarely, hypersensitivity reactions or severe allergic responses may occur.

Caspofungin 50 mg Injection is indicated for the treatment of serious fungal infections such as invasive candidiasis, esophageal candidiasis, and invasive aspergillosis in patients who are refractory to or intolerant of other antifungal therapies. It works by inhibiting the synthesis of the fungal cell wall, leading to effective control of infection.

This medication should be administered under strict medical supervision. Monitor liver function during therapy. Inform your doctor about any liver disease, allergies, or ongoing medications. Complete the full course of treatment as prescribed for optimal results

Store in a cool, dry place below 25°C. Protect from light and moisture. Keep in original packaging and out of reach of children. Use as directed after reconstitution.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Caspofung 50 Injection in the PCD pharma franchise market?

Caspofung 50 Injection, containing Caspofungin 50mg, has strong demand in the hospital antifungal and critical care segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners focusing on ICU, oncology support, and infectious disease portfolios.

Why should medical distributors include Caspofung 50 Injection in their product range?

Medical distributors and agencies can benefit from the consistent hospital demand for echinocandin-class antifungals used in serious fungal infections such as invasive candidiasis and aspergillosis, especially in immunocompromised and ICU patients. Caspofung 50 Injection helps strengthen a comprehensive antifungal and critical care product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Caspofung 50 Injection?

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Caspofung 50 Injection?

What benefits do wholesalers get by partnering for Caspofung 50 Injection distribution?

Wholesalers and medical agencies benefit from attractive business margins, reliable product availability, professional support, and access to a trusted antifungal injectable product range when partnering for Caspofung 50 Injection distribution.

How can I become a distributor or franchise partner for Caspofung 50 Injection?

Medical distributors, stockists, and wholesalers interested in Caspofung 50 Injection can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.